Clinical Trial Update: Safety and Efficacy on Cell-based Therapy in Patients With Recent Large Acute Myocardial Infarction [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a cell-based therapy for patients with a recent large acute myocardial infarction has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Myocardial Infarction

Drugs mentioned

• cell-based therapy (undisclosed)

Snippet

Sponsor: Duke University | Conditions: Acute Myocardial Infarction, Heart Failure | Phase 2 | Status: WITHDRAWN